Gates MRI Licenses Calibr Tuberculosis Treatment Discovery: PHARMA: Novel Compound Can Potentially Complement Current Care.
用户zXqBMD2rfL_4
5天前
40
10
已关闭
DOI:
文献链接:
其他信息:
J Clemetson
San Diego Business Journal, 2023
go.gale.com
… We hope our collaboration with Gates MRI to advance CLB073 will ultimately be able to … In
preclinical mouse studies, CLB073 significantly enhanced efficacy of the Nix-TB drug regimen-…

